JP2023510741A5 - - Google Patents
Info
- Publication number
- JP2023510741A5 JP2023510741A5 JP2022541787A JP2022541787A JP2023510741A5 JP 2023510741 A5 JP2023510741 A5 JP 2023510741A5 JP 2022541787 A JP2022541787 A JP 2022541787A JP 2022541787 A JP2022541787 A JP 2022541787A JP 2023510741 A5 JP2023510741 A5 JP 2023510741A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- inflammation
- betamethasone
- dexamethasone
- prednisone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025076816A JP2025118775A (ja) | 2020-01-07 | 2025-05-02 | 標的指向性ステロイド化合物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062958102P | 2020-01-07 | 2020-01-07 | |
| US62/958,102 | 2020-01-07 | ||
| US202063030020P | 2020-05-26 | 2020-05-26 | |
| US63/030,020 | 2020-05-26 | ||
| PCT/US2021/012532 WO2021142145A1 (en) | 2020-01-07 | 2021-01-07 | Targeted steroid conjugates |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025076816A Division JP2025118775A (ja) | 2020-01-07 | 2025-05-02 | 標的指向性ステロイド化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023510741A JP2023510741A (ja) | 2023-03-15 |
| JP2023510741A5 true JP2023510741A5 (enExample) | 2024-01-17 |
| JP7678813B2 JP7678813B2 (ja) | 2025-05-16 |
Family
ID=76787625
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022541787A Active JP7678813B2 (ja) | 2020-01-07 | 2021-01-07 | 標的指向性ステロイド化合物 |
| JP2025076816A Pending JP2025118775A (ja) | 2020-01-07 | 2025-05-02 | 標的指向性ステロイド化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025076816A Pending JP2025118775A (ja) | 2020-01-07 | 2025-05-02 | 標的指向性ステロイド化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230331767A1 (enExample) |
| EP (1) | EP4087580A4 (enExample) |
| JP (2) | JP7678813B2 (enExample) |
| KR (1) | KR20220124742A (enExample) |
| CN (1) | CN115003308A (enExample) |
| AU (1) | AU2021205255A1 (enExample) |
| BR (1) | BR112022013478A2 (enExample) |
| CA (1) | CA3163268A1 (enExample) |
| IL (2) | IL326516A (enExample) |
| MX (1) | MX2022008343A (enExample) |
| WO (1) | WO2021142145A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115232186B (zh) * | 2022-07-07 | 2024-03-01 | 武汉工程大学 | 一种泼尼松磷酸酯及其盐的制备方法和应用 |
| WO2024025845A1 (en) * | 2022-07-25 | 2024-02-01 | Sorrento Therapeutics, Inc. | Folate-conjugated drugs and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6379698B1 (en) * | 1999-04-06 | 2002-04-30 | Isis Pharmaceuticals, Inc. | Fusogenic lipids and vesicles |
| AU2003216445A1 (en) * | 2002-02-27 | 2003-09-09 | The Medical College Of Ohio | Therapeutic methods for acute myeloid leukemia |
| JP5175723B2 (ja) | 2005-07-05 | 2013-04-03 | パーデュー・リサーチ・ファウンデーション | 単球介在性疾患を治療するための組成物の調製 |
| WO2007139815A2 (en) | 2006-05-23 | 2007-12-06 | Purdue Research Foundation | Imaging and therapeutic method using progenitor cells |
| US8507455B2 (en) * | 2007-12-04 | 2013-08-13 | Alnylam Pharmaceuticals, Inc. | Folate conjugates |
| WO2011150392A1 (en) * | 2010-05-28 | 2011-12-01 | Purdue Research Foundation | Delivery of therapeutic agents to inflamed tissues using folate-targeted agents |
| EA201590622A1 (ru) | 2012-10-16 | 2015-10-30 | Эндосайт, Инк. | Конъюгаты для доставки лекарственного средства, содержащие не встречающиеся в природе аминокислоты, и способы применения |
| HK1259487A1 (zh) * | 2016-02-04 | 2019-11-29 | Hangzhou Dac Biotech Co. Ltd. | 特定的共轭连接子，特定的免疫共轭物，制造和使用这些共轭物的方法 |
| WO2018045245A1 (en) * | 2016-09-02 | 2018-03-08 | Sirenas Llc | Cyclic peptide analogs and conjugates thereof |
| KR20220147719A (ko) * | 2016-11-14 | 2022-11-03 | 항저우 디에이씨 바이오테크 씨오, 엘티디 | 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용 |
| AU2020279979A1 (en) * | 2019-05-20 | 2021-11-25 | Les Laboratoires Servier | Mcl-1 inhibitor antibody-drug conjugates and methods of use |
-
2021
- 2021-01-07 IL IL326516A patent/IL326516A/en unknown
- 2021-01-07 AU AU2021205255A patent/AU2021205255A1/en active Pending
- 2021-01-07 CN CN202180008293.6A patent/CN115003308A/zh active Pending
- 2021-01-07 CA CA3163268A patent/CA3163268A1/en active Pending
- 2021-01-07 EP EP21738610.1A patent/EP4087580A4/en active Pending
- 2021-01-07 MX MX2022008343A patent/MX2022008343A/es unknown
- 2021-01-07 WO PCT/US2021/012532 patent/WO2021142145A1/en not_active Ceased
- 2021-01-07 US US17/758,492 patent/US20230331767A1/en active Pending
- 2021-01-07 KR KR1020227026839A patent/KR20220124742A/ko active Pending
- 2021-01-07 BR BR112022013478A patent/BR112022013478A2/pt unknown
- 2021-01-07 JP JP2022541787A patent/JP7678813B2/ja active Active
-
2022
- 2022-06-27 IL IL294339A patent/IL294339B2/en unknown
-
2025
- 2025-05-02 JP JP2025076816A patent/JP2025118775A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10632131B2 (en) | Controlled release system | |
| US20250092083A1 (en) | Sterol based ionizable lipids and lipid nanoparticles comprising the same | |
| CA2837979C (en) | Dendrimers comprising terminal pharmaceutically active agents and terminal pharmacokinetic modifying agents | |
| Pan et al. | Biodistribution and pharmacokinetic studies of bone-targeting N-(2-hydroxypropyl) methacrylamide copolymer–alendronate conjugates | |
| Wang et al. | Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-hydroxypropyl) methacrylamide (HPMA) copolymers | |
| CN116867500A (zh) | 两性离子脂质纳米颗粒组合物和使用方法 | |
| JP2009542649A5 (enExample) | ||
| CA3137081A1 (en) | Compositions and methods of manufacturing star polymers for ligand display and/or drug delivery | |
| JP2020512336A5 (enExample) | ||
| AU2024203637A1 (en) | Formulations of phosphoramidate derivatives of nucleoside drugs | |
| TW201945007A (zh) | 磷酸酯衍生物之調配物 | |
| WO2014205126A1 (en) | Chemical structures for localized delivery of therapeutic agents | |
| EP3860646A1 (en) | Aromatic ring substituted amphiphilic polymers as drug delivery systems | |
| US20220162382A1 (en) | Production of nanoparticles and microparticles | |
| US11623009B2 (en) | Bone fracture repair by targeting of agents that promote bone healing | |
| JP2015506983A5 (enExample) | ||
| JP2017502984A5 (enExample) | ||
| JP2021505550A5 (enExample) | ||
| JP2025502191A5 (enExample) | ||
| JP2022501341A (ja) | ポリマーベースの高分子プロドラッグ | |
| WO2008075706A1 (ja) | 間質性肺炎治療剤 | |
| WO2019009434A1 (ja) | 薬物送達用高分子ミセル | |
| WO2025207803A1 (en) | Lipid compounds, compositions and methods of use thereof | |
| CA3143104A1 (en) | Dissacharide formulations for controlled drug release | |
| CA2993621A1 (en) | Compositions comprising s1p receptor modulators |